pharmaceuticals-and-healthcare

Global Biosimilar Drug Market Insights,Forecast to 2025


Published On : Oct 2018

Category : Pharmaceutical

No. of Pages : 112 pages

  • $3900
  • $7800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the global market size of Biosimilar Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biosimilar Drug in these regions.
This research report categorizes the global Biosimilar Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why were using our more than 35 years of biologics experience to develop high-quality biosimilars.

First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.

Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars.

Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.

Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries.

At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.

In 2017, the global Biosimilar Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Biosimilar Drug market based on company, product type, application and key regions.

The various contributors involved in the value chain of Biosimilar Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Biosimilar Drug include
Amgen
Eli Lilly
Novartis
CP Guojian Pharma
Biotech Pharma

Market Size Split by Type
Injection
Tablets
Other Types
Market Size Split by Application
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Biosimilar Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Biosimilar Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Biosimilar Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biosimilar Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Biosimilar Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biosimilar Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K DDD). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biosimilar Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

In the recent times, the global market for Global biosimilar drug market insightsforecast to 2025 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global biosimilar drug market insightsforecast to 2025 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global biosimilar drug market insightsforecast to 2025 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global biosimilar drug market insightsforecast to 2025 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global biosimilar drug market insightsforecast to 2025 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global biosimilar drug market insightsforecast to 2025, including the definition, classification, and industry chain structure of Global biosimilar drug market insightsforecast to 2025, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global biosimilar drug market insightsforecast to 2025.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global biosimilar drug market insightsforecast to 2025 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global biosimilar drug market insightsforecast to 2025, implemented in each of the geographical segments. The predominant applications of the Global biosimilar drug market insightsforecast to 2025 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global biosimilar drug market insightsforecast to 2025 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global biosimilar drug market insightsforecast to 2025 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Biosimilar Drug
Figure Global Biosimilar Drug Production (K DDD) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Biosimilar Drug Production Market Share by Types (Product Category) in 2017
Figure Injection Product Picture
Table Major Manufacturers of Injection
Figure Tablets Product Picture
Table Major Manufacturers of Tablets
Figure Other Types Product Picture
Table Major Manufacturers of Other Types
Table Global Biosimilar Drug Market Size Growth Rate by Application 2018-2025 (K DDD)
Figure Ankylosing Spondylitis
Figure Tumor
Figure Rheumatoid Arthrtis
Figure Cardiovascular
Figure Other Application
Figure Biosimilar Drug Report Years Considered
Figure Global Biosimilar Drug Market Size 2016-2025 (Million US$)
Figure Global Biosimilar Drug Sales 2016-2025 (K DDD)
Table Global Biosimilar Drug Market Size by Regions 2016-2025 (K DDD) & (Million US$)
Table Global Biosimilar Drug Sales by Regions 2016-2025 (K DDD)
Table Global Biosimilar Drug Sales Market Share by Regions 2016-2025
Figure Global Biosimilar Drug Sales Market Share by Regions 2016-2025
Figure 2017 Global Biosimilar Drug Sales Market Share by Regions
Table Global Biosimilar Drug Revenue by Regions 2016-2025 (Million US$)
Table Global Biosimilar Drug Revenue Market Share by Regions 2016-2025
Figure Global Biosimilar Drug Revenue Market Share by Regions 2016-2025
Figure 2017 Global Biosimilar Drug Revenue Market Share by Regions
Table Global Biosimilar Drug Sales by Manufacturers (2016-2018) (K DDD)
Table Global Biosimilar Drug Sales Share by Manufacturers (2016-2018)
Figure Global Biosimilar Drug Sales Share by Manufacturers in 2017
Table Biosimilar Drug Revenue by Manufacturers (2016-2018) (Million US$)
Table Biosimilar Drug Revenue Share by Manufacturers (2016-2018)
Figure Biosimilar Drug Value Share by Manufacturers in 2017
Table Global Biosimilar Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Biosimilar Drug Price (2016-2018) (USD/DDD)
Table Biosimilar Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Biosimilar Drug Product Category
Table Date of International Manufacturers Enter into Biosimilar Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Biosimilar Drug Sales by Type (2016-2025) (K DDD)
Table Global Biosimilar Drug Sales Share by Type (2016-2025)
Figure Global Biosimilar Drug Sales Market Share by Type (2016-2025)
Figure Global Biosimilar Drug Sales Market Share by Type in 2017
Table Global Biosimilar Drug Revenue by Type (2016-2025) (Million US$)
Table Global Biosimilar Drug Revenue Share by Type (2016-2025)
Figure Global Biosimilar Drug Revenue Market Share by Type (2016-2025)
Figure Global Biosimilar Drug Revenue Market Share by Type in 2017
Table Biosimilar Drug Price by Type 2013-2018 (USD/DDD)
Table Global Biosimilar Drug Sales by Application (2016-2025) (K DDD)
Table Global Biosimilar Drug Sales Share by Application (2016-2025)
Figure Global Sales Biosimilar Drug Market Share by Application (2016-2025)
Figure Global Sales Biosimilar Drug Market Share by Application (2016-2025)
Figure North America Biosimilar Drug Sales Growth Rate 2016-2025 (K DDD)
Figure North America Biosimilar Drug Revenue Growth Rate 2016-2025 (Million US$)
Table North America Biosimilar Drug Sales by Countries (2016-2025) (K DDD)
Table North America Biosimilar Drug Sales Market Share by Countries (2016-2025)
Figure 2017 North America Biosimilar Drug Sales Market Share by Countries
Table North America Biosimilar Drug Revenue by Countries (2016-2025) (Million US$)
Table North America Biosimilar Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Biosimilar Drug Revenue Market Share by Countries
Figure United States Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure United States Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Canada Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Mexico Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Table North America Biosimilar Drug Sales by Type (2016-2025) (K DDD)
Table North America Biosimilar Drug Sales Market Share by Type (2016-2025)
Figure 2017 North America Biosimilar Drug Market Share by Type
Table North America Biosimilar Drug Sales by Application (2016-2025) (K DDD)
Table North America Biosimilar Drug Sales Market Share by Application (2016-2025)
Figure 2017 North America Biosimilar Drug Market Share by Application
Table North America Biosimilar Drug Sales by Company (2016-2018) (K DDD)
Table North America Biosimilar Drug Sales Market Share by Company (2016-2018)
Figure North America Biosimilar Drug Sales Market Share by Company in 2017
Figure Europe Biosimilar Drug Sales Growth Rate 2016-2025 (K DDD)
Figure Europe Biosimilar Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Biosimilar Drug Sales by Countries (2016-2025) (K DDD)
Table Europe Biosimilar Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Biosimilar Drug Sales Market Share by Countries
Table Europe Biosimilar Drug Revenue by Countries (2016-2025) (Million US$)
Table Europe Biosimilar Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Biosimilar Drug Revenue Market Share by Countries
Figure Germany Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Germany Biosimilar Drug Revenue Growth Rate (2016-2025) (K DDD)
Figure France Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure France Biosimilar Drug Revenue Growth Rate (2016-2025) (K DDD)
Figure UK Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure UK Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Italy Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Russia Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Biosimilar Drug Sales by Type (2016-2025) (K DDD)
Table Europe Biosimilar Drug Sales Market Share by Type (2016-2025)
Figure 2017 Europe Biosimilar Drug Market Share by Type
Table Europe Biosimilar Drug Sales by Application (2016-2025) (K DDD)
Table Europe Biosimilar Drug Sales Market Share by Application (2016-2025)
Figure 2017 Europe Biosimilar Drug Market Share by Application
Table Europe Biosimilar Drug Sales by Company (2016-2018) (K DDD)
Table Europe Biosimilar Drug Sales Market Share by Company (2016-2018)
Figure Europe Biosimilar Drug Sales Market Share by Company in 2017
Figure Asia Pacific Biosimilar Drug Sales Growth Rate 2016-2025 (K DDD)
Figure Asia Pacific Biosimilar Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Biosimilar Drug Sales by Countries (2016-2025) (K DDD)
Table Asia Pacific Biosimilar Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Biosimilar Drug Sales Market Share by Countries
Table Asia Pacific Biosimilar Drug Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Biosimilar Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Biosimilar Drug Revenue Market Share by Countries
Figure China Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure China Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Japan Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Korea Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure India Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure India Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Australia Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Indonesia Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Malaysia Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Philippines Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Thailand Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Vietnam Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Singapore Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Biosimilar Drug Sales by Type (2016-2025) (K DDD)
Table Asia Pacific Biosimilar Drug Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Biosimilar Drug Market Share by Type
Table Asia Pacific Biosimilar Drug Sales by Application (2016-2025) (K DDD)
Table Asia Pacific Biosimilar Drug Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Biosimilar Drug Market Share by Application
Table Asia Pacific Biosimilar Drug Sales by Company (2016-2018) (K DDD)
Table Asia Pacific Biosimilar Drug Sales Market Share by Company (2016-2018)
Figure Asia Pacific Biosimilar Drug Sales Market Share by Company in 2017
Figure Central & South America Biosimilar Drug Sales Growth Rate 2016-2025 (K DDD)
Figure Central & South America Biosimilar Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Biosimilar Drug Sales by Countries (2016-2025) (K DDD)
Table Central & South America Biosimilar Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Biosimilar Drug Sales Market Share by Countries
Table Central & South America Biosimilar Drug Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Biosimilar Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Biosimilar Drug Revenue Market Share by Countries
Figure Brazil Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Brazil Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Argentina Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Biosimilar Drug Sales by Type (2016-2025) (K DDD)
Table Central & South America Biosimilar Drug Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Biosimilar Drug Market Share by Type
Table Central & South America Biosimilar Drug Sales by Application (2016-2025) (K DDD)
Table Central & South America Biosimilar Drug Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Biosimilar Drug Market Share by Application
Table Central & South America Biosimilar Drug Sales by Company (2016-2018) (K DDD)
Table Central & South America Biosimilar Drug Sales Market Share by Company (2016-2018)
Figure Central & South America Biosimilar Drug Sales Market Share by Company in 2017
Figure Middle East and Africa Biosimilar Drug Sales Growth Rate 2016-2025 (K DDD)
Figure Middle East and Africa Biosimilar Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Biosimilar Drug Sales by Countries (2016-2025) (K DDD)
Table Middle East and Africa Biosimilar Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Biosimilar Drug Sales Market Share by Countries
Table Middle East and Africa Biosimilar Drug Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Biosimilar Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Biosimilar Drug Revenue Market Share by Countries
Figure GCC Countries Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure GCC Countries Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Turkey Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure Egypt Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Biosimilar Drug Sales Growth Rate (2016-2025) (K DDD)
Figure South Africa Biosimilar Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Biosimilar Drug Sales by Type (2016-2025) (K DDD)
Table Middle East and Africa Biosimilar Drug Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Biosimilar Drug Market Share by Type
Table Middle East and Africa Biosimilar Drug Sales by Application (2016-2025) (K DDD)
Table Middle East and Africa Biosimilar Drug Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Biosimilar Drug Market Share by Application
Table Middle East and Africa Biosimilar Drug Sales by Company (2016-2018) (K DDD)
Table Middle East and Africa Biosimilar Drug Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Biosimilar Drug Sales Market Share by Company in 2017
Table Amgen Company Details
Table Amgen Biosimilar Drug Sales (K DDD), Revenue (Million US$), Price (USD/DDD) and Gross Margin (2016-2018)
Table Amgen Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Biosimilar Drug Sales (K DDD), Revenue (Million US$), Price (USD/DDD) and Gross Margin (2016-2018)
Table Eli Lilly Recent Development
Table Novartis Company Details
Table Novartis Biosimilar Drug Sales (K DDD), Revenue (Million US$), Price (USD/DDD) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table CP Guojian Pharma Company Details
Table CP Guojian Pharma Biosimilar Drug Sales (K DDD), Revenue (Million US$), Price (USD/DDD) and Gross Margin (2016-2018)
Table CP Guojian Pharma Recent Development
Table Biotech Pharma Company Details
Table Biotech Pharma Biosimilar Drug Sales (K DDD), Revenue (Million US$), Price (USD/DDD) and Gross Margin (2016-2018)
Table Biotech Pharma Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Biosimilar Drug Value Chain
Table Typical Suppliers of Key Biosimilar Drug Raw Material
Table Biosimilar Drug Customers List
Table Biosimilar Drug Sales Channels
Table Biosimilar Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top